The hyper-consolidation, with little to no regulatory oversight, creates inappropriate negotiating leverage that discourages competition and makes it difficult to achieve transparency, affordability, and timely access for patients.
Menendez criticizes the lack of oversight in the PBM market.
Share
More from Bob Menendez
in the span of 12 weeks, our country was shaken by the tragic killings of Renee Good and Alex Pretti, who lost their lives because of the violent and reckless choices that the Trump administration has made. When I went to Minneapolis…
Mr. Speaker, House Republicans ended 2025 by failing to extend Affordable Care Act tax credits causing healthcare costs to skyrocket for millions of Americans. Since President Trump took office, electricity prices have gone up by 13…
The ability for drone operators to conduct beyond visual line of sight (BVLOS) operations holds promise in addressing critical challenges, such as reducing traffic congestion and lowering carbon emissions.
Other voices in this conversation
